title: Intestinal permeability and toxicity of second-line therapeutic agents in ovarian cancer.
authors.forename: Bohuslav
authors.initials: B
authors.lastname: Melichar
authors.forename: Radomír
authors.initials: R
authors.lastname: Hyspler
authors.forename: Emanuela
authors.initials: E
authors.lastname: Dragounová
authors.forename: Hana
authors.initials: H
authors.lastname: Kalábová
authors.forename: Josef
authors.initials: J
authors.lastname: Dvorák
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000494:pharmacology*; D015415:Biomarkers / Q000378:metabolism; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D002277:Carcinoma / Q000188:drug therapy* / Q000378:metabolism*; D002945:Cisplatin / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D000077146:Irinotecan; D007792:Lactulose / Q000097:blood / Q000378:metabolism* / Q000652:urine; D002955:Leucovorin / Q000008:administration & dosage; D008353:Mannitol / Q000097:blood / Q000378:metabolism* / Q000652:urine; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D010539:Permeability; D019772:Topotecan / Q000008:administration & dosage; D000093542:Gemcitabine
chemical_list: D015415:Biomarkers; D003841:Deoxycytidine; D008353:Mannitol; D007792:Lactulose; D000077146:Irinotecan; D019772:Topotecan; D002945:Cisplatin; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin; D000093542:Gemcitabine